Table 2.
Preoperative echocardiographic parameters stratified according to 30-day mortality
Variable* | Survivors (n=199) | Dead (n=19) |
P value |
LVEF %, (n=212) | 0.751 | ||
≥50 | 100(50) | 10(53) | |
31–49 | 72(36) | 7 (37) | |
≤30 | 22(11) | 1 (5) | |
LVLS, (n=198) | −11.1±3.8 | −10.9±3.6 | 0.783 |
MAPSE septal, cm (n=212) | 0.70±0.27 | 0.67±0.31 | 0.691 |
MAPSE lateral, cm (n=212) | 0.99±0.32 | 1.0±0.31 | 0.844 |
IVSDd, cm (n=202) | 1.2±0.3 | 1.3±0.3 | 0.158 |
AVA, cm2 (n=215) | 0.63±0.21 | 0.58±0.20 | 0.407 |
AVA index, cm2/m2 (n=215) | 0.34±0.11 | 0.34±0.11 | 0.802 |
AV gradient max, mm Hg (n=215) | 84±24 | 77±20 | 0.189 |
AV gradient mean, mm Hg (n=215) | 52±15 | 47±12 | 0.202 |
AV max velocity, m/s (n=216) | 453±67 | 430±58 | 0.162 |
SV LVOT index, ml/m2 (n=216) | 37±11 | 35±12 | 0.559 |
LVOT diameter, cm | 2.1±0.25 | 2.1±0.23 | 0.348 |
E/é (n=148) | 19.2±8.1 | 18.1±9.7 | 0.644 |
E/A (n=147) | 1.1±0.6 | 0.8±0.5 | 0.159 |
MV deceleration time, ms (n=215) | 227±92 | 221±89 | 0.769 |
MV E, cm/s (n=215) | 96±34 | 89±39 | 0.454 |
LA volume index, mL/m2 (n=204) | 53±20 | 53±22 | 0.995 |
MR moderate to severe (n=209) | 38(20) | 7 (37) | 0.079 |
AR moderate to severe (n=213) | 35(18) | 3 (16) | 0.777 |
Mitral stenosis | 9 (5) | 1 (5) | 0.816 |
SPAP, mm Hg (n=215) | 0.033 | ||
>60 | 16(8) | 5 (26) | |
30–60 | 120(60) | 10(53) | |
<30 | 63(32) | 4 (21) | |
TAPSE, cm (n=204) | 1.6±0.5 | 1.7±0.5 | 0.405 |
TASV, cm/s (n=133) | 9.5±3.2 | 10.9±3.3 | 0.140 |
FAC, % (n=197) | 36±13 | 37±9 | 0.655 |
RVEDA, cm2 (n=197) | 20±5 | 21±5 | 0.469 |
RVESA, cm2 (n=197) | 13±5 | 13±3 | 0.872 |
TR moderate to severe (n=213) | 40(21) | 5 (26) | 0.562 |
RVLS, % (n=171) | −16±7 | −16±6 | 0.888 |
Values are mean±SD or n(%).
*Numbers in brackets indicate the number of cases where the measurement was available.
AR, aortic regurgitation;AV, aortic valve;AVA, aortic valve area;FAC, fractional area change;IVSDd, intraventricular septum diameter in diastole;LA, left atrium;LVLS, left ventricular longitudinal strain;LVEF, left ventricular ejection fraction;LVOT, left ventricular outflow tract;MAPSE, mitral annular plane systolic excursion;MR, mitral regurgitation;MV, mitral valve;RVEDA, right ventricular end-diastolic area;RVESA, right ventricular end-systolic area;RVLS, right ventricular longitudinal strain;SPAP, systolic pulmonary arterial pressure;SV, stroke vol;TAPSE, tricuspid annular peak systolic excursion;TASV, tricuspid annular systolic velocity;TR, tricuspid regurgitation.